Planning benchmark study for SBRT of liver metastases: Results of the DEGRO/DGMP working group stereotactic radiotherapy and radiosurgery.

Moustakis, C; Blanck, O; Chan, Mkh; Boda-Heggemann, J; Andratschke, N; Duma, M-N; Albers, D; Bäumer, C; Fehr, R; Körber, S A; Schmidhalter, D; Alraun, M; Baus, W W; Beckers, E; Dierl, M; Droege, S; Ebrahimi Tazehmahalleh, F; Fleckenstein, J; Guckenberger, M; Heinz, C; ... (2022). Planning benchmark study for SBRT of liver metastases: Results of the DEGRO/DGMP working group stereotactic radiotherapy and radiosurgery. International journal of radiation oncology, biology, physics, 113(1), pp. 214-227. Elsevier 10.1016/j.ijrobp.2022.01.008

[img]
Preview
Text
1-s2.0-S0360301622000189-main.pdf - Accepted Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (1MB) | Preview

PURPOSE

To investigate, if liver SBRT treatment planning can be harmonized across different treatment planning systems, delivery techniques and institutions by using a specific prescription method and to minimize the knowledge gap concerning inter-system and inter-user differences. To provide best practice guidelines for all used techniques.

METHODS

A multiparametric specification of target dose (GTVD50%, GTVD0.1cc, GTVV90%, PTVV70%) with a prescription dose of GTVD50% = 3 × 20 Gy and OAR limits were distributed with CTs and structure sets from three liver metastases patients. Thirty-five institutions provided 132 treatment plans using different irradiation techniques. These plans were first analyzed for target and OAR doses. Four different renormalization methods were performed (PTVDmin, PTVD98%, PTVD2%, PTVDmax). The resulting 660 treatments plans were evaluated regarding target doses in order to study the effect of dose renormalization to different prescription methods. A relative scoring system was used for comparisons.

RESULTS

GTVD50% prescription can be performed in all systems. Treatment plan harmonization was overall successful with standard deviations for Dmax, PTVD98%, GTVD98% and PTVDmean of 1.6 Gy, 3.3 Gy, 1.9 Gy and 1.5 Gy, respectively. Primary analysis showed 55 major deviations from clinical goals in 132 plans, while in only <20% of deviations GTV/PTV dose was traded for meeting OAR limits. GTVD50% prescription produced the smallest deviation from target planning objectives and between techniques, followed by the PTVDmax, PTVD98%, PTVD2% and PTVDmin prescription. Deviations were significant for all combinations but for the PTVDmax prescription compared with GTVD50% and PTVD98%. Based on the various dose prescription methods, all systems significantly differed from each other, while GTVD50% and PTVD98% prescription showed the least differences between the systems.

CONCLUSIONS

This study showed the feasibility of harmonizing liver SBRT treatment plans across different treatment planning systems and delivery techniques when a sufficient set of clinical goals is given.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology > Medical Radiation Physics

UniBE Contributor:

Schmidhalter, Daniel

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0360-3016

Publisher:

Elsevier

Language:

English

Submitter:

Basak Ginsbourger

Date Deposited:

18 Feb 2022 12:20

Last Modified:

24 Jan 2023 00:25

Publisher DOI:

10.1016/j.ijrobp.2022.01.008

PubMed ID:

35074434

BORIS DOI:

10.48350/165025

URI:

https://boris.unibe.ch/id/eprint/165025

Actions (login required)

Edit item Edit item
Provide Feedback